Company profilePharmaceutical#509 of 1,318 in Pakistan✓ No DRAP alerts

CORE HEALTH

Pharmaceutical company · 26 brands · 25 molecules

Ranked #54 of 146 companies in Antiemetics & Antinauseants

26 registered products 11 pharmaceutical brands 25 distinct molecules 0 DRAP alerts

Company overview

26
registered products
11
pharmaceutical brands
25
distinct molecules
12
therapeutic classes
0
DRAP alerts

CORE HEALTH is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 26 product registrations across 25 distinct molecules. Its portfolio is concentrated in Antiemetics & Antinauseants and Other Beta-Lactam, Cephalosporins & Penems. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by CORE

16 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) 2
Antiinflammatory And Antirheumatic Products 2
Vitamin B12 Plain 1

Top molecules by brand count

Omeprazole2 brands
Itopride1 brand
Tizanidine1 brand
Nutritional Supplement / Multivitamin1 brand
Ossein Mineral Complex1 brand

Therapeutic classes

Antiemetics & Antinauseants · 2Other Beta-Lactam, Cephalosporins & Penems · 2Quinolone Antibacterials · 2Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 2Antianemic, Iron Preparations · 1Drugs For Obstructive Airway Diseases, Systemic · 1Muscle Relaxant · 1Calcium, Combinations With Vitamin D And Other Drugs · 1Vitamin A, D & Combinations · 1Vitamin B12 Plain · 1Anti-Gout Preparations · 1Macrolides, Lincosamides And Streptogramins · 1

Price band (DRAP official ceilings)

Registered products priced by source
DVAGO15 products · Rs 108.78 – Rs 997.56
Median across source: Rs 255.57

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Horizon Pharmaceuticals (Pvt) Limited holds 130 molecules not in this portfolio
000 I.UAcyclovirAlbendazoleAmlodipineAmoxicillinAmoxycillin Base
GETZ PHARMA PAKISTAN (PVT) LTD. holds 267 molecules not in this portfolio
),Formoterol3 ) 20Mg} Folic AcidAcetazolamideAcyclovirAdrenalineAlbendazole
SHROOQ PHARMACEUTICALS holds 21 molecules not in this portfolio
AcitretinAcyclovirAcyclovir Inf/OralCefiximeCiprofloxacinDiclofenac

Get the full profile for CORE

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.